Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rationale for intensive intravesical chemotherapy for superficial bladder cancer.

× No keyword cloud information.

21 in total

Review 1. Current approaches in the treatment of bladder cancer and policy in Marmara University Hospital.

Authors: D Ersev; Y Ilker; F Simşek; A Akdaş
Journal: Int Urol Nephrol Date: 1990 Impact factor: 2.370

2. The Nd:YAG laser and methylene blue staining in the diagnosis and treatment of premalignant vesical lesions and carcinoma in situ (CIS).

Authors: F Gaboardi; R Bordinazzo; L Galli
Journal: Int Urol Nephrol Date: 1989 Impact factor: 2.370

3. Prophylactic treatment for superficial bladder cancer following transurethral resection.

Authors: Y Hirao; E Okajima; S Ohara; S Ozono; T Hiramatsu; K Yoshida; K Yamada; H Aoyama; M Hashimoto; S Watanabe
Journal: Cancer Chemother Pharmacol Date: 1987 Impact factor: 3.333

4. Prophylaxis of superficial bladder cancer with instillation of adriamycin or mitomycin C.

Authors: S Isaka; T Okano; J Shimazaki; T Igarashi; S Murakami; T Higa; T Ishikawa; S Zama; S Kataumi; Z Kataumi
Journal: Cancer Chemother Pharmacol Date: 1987 Impact factor: 3.333

Review 5. Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors: G L Plosker; D Faulds
Journal: Drugs Date: 1993-05 Impact factor: 9.546

6. Early adjuvant adriamycin in superficial bladder carcinoma.

Authors: C C Schulman; L J Denis; W Oosterlinck; W De Sy; M Chantrie; C Bouffioux; P J Van Cangh; P Van Erps
Journal: Cancer Chemother Pharmacol Date: 1983 Impact factor: 3.333

7. Effects of intravesical instillation of antitumor drugs on the induction of preneoplastic bladder lesions in rats.

Authors: M Ohtani; S Fukushima; N Ito; K Koiso; T Niijima
Journal: Cancer Chemother Pharmacol Date: 1983 Impact factor: 3.333

8. Prophylactic chemotherapy with anthracyclines (adriamycin, epirubicin, and pirarubicin) for primary superficial bladder cancer. The Hokkaido University Bladder Cancer Collaborative Group.

Authors: N Shinohara; K Nonomura; M Tanaka; S Nagamori; F Takakura; T Seki; T Koyanagi; M Togashi; A Maru
Journal: Cancer Chemother Pharmacol Date: 1994 Impact factor: 3.333

9. A phase II study of prophylactic intravesical chemotherapy with 4'-epirubicin in recurrent superficial bladder cancer: comparison of 4'-epirubicin and adriamycin.

Authors: T Shuin; Y Kubota; S Noguchi; M Hosaka; T Miura; I Kondo; S Fukushima; E Ishizuka; A Furuhata; M Moriyama
Journal: Cancer Chemother Pharmacol Date: 1994 Impact factor: 3.333

10. Intravesical idarubicin--a phase-I study.

Authors: W Schultze-Seemann; K Mross; K Burk; H Sommerkamp
Journal: Urol Res Date: 1994